Key Benefits of Digitized Cleaning Validation Program

แชร์
ฝัง
  • เผยแพร่เมื่อ 6 มิ.ย. 2024
  • 11 Jul 2023
    9.00-10.00am SGT | Online
    Cleaning validation is a complex process. Over the years, the industry has moved on with a structured lifecycle approach following FDA Process Validation Lifecycle principal guidance. Using old processes, it remains a challenge to eliminate human errors. This presentation shows how to automate and digitize your cleaning validation program that will help users perform cleaning validation activities in consistent manner to ensure an efficient, safe, and compliant cleaning validation program.
    Topics covered in this session:
    Pain Points of Paper-based Cleaning Validation
    Cleaning Validation Lifecycle Model
    Automated Product and Equipment Assessments
    Automated Worst Case Product and Equipment Identification
    Critical Cleaning Matrices Development
    Manage Cleaning Validation Program
    Cleaning Validation Documentation
    Takeaways:
    How to digitize the end-to-end cleaning validation life cycle
    Project Management and Task Dependency
    Utilizing the power of data for the dashboard and quality metrics
    Led by:
    Sunil Patel, Director of Product Management and COE, ValGenesis. Inc.
    Sunil has over 20+ years of experience working in the engineering and validation fields of cGMP / FDA / EU / ISO regulated industry sectors.
    Sunil has a strong background in Cleaning Validation (CIP, COP, Manual), Process Validation, Process Design, Clean Utilities (WFI, PW, Clean Steam, Clean Air, Clean Gases), HVAC, Project Management, Sterilization and Processing Equipment Validation. Further expertise includes Process Optimization/Improvement, Regulatory Compliance and Risk Management methodologies for the pharmaceutical and biologics industry.
    Prior to joining ValGenesis, Sunil has had a variety of Validation roles as consultant and corporate employee with increased responsibilities within the Pharmaceutical and Biologics industry, including Catalent, Eisai, Pfizer, Teva and Novartis.

ความคิดเห็น • 1

  • @user-us7yy2lq8i
    @user-us7yy2lq8i 10 หลายเดือนก่อน

    Nice subjective presentation